Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Findings from a pre-specified second interim analysis of overall survival and updates in other OlympiA study endpoints
Findings from a pooled data analysis of the SAFIR02-BREAST and SAFIR-PI3K studies
Findings from the NordICC Study Group trial
Sorafenib Accord is a generic of Nexavar, which has been authorised in the EU since 2006
Efficacy was evaluated in TAS-120-101 study in patients with previously treated, unresectable, locally advanced, or metastatic intrahepatic cholangiocarcinoma harbouring a FGFR2 gene fusion or other rearrangement
Findings from a phase I, dose-escalation study of a second-generation CAR T-cells in patients with relapsed or refractory multiple myeloma
Findings from the CheckMate 915 study primary endpoints of recurrence-free survival in the all randomised population and in patients with tumour PD-L1 expression < 1%
Passive immunisation with tixagevimab and cilgavimab may not be effective
Evidence for efficacy is based on the results from the LIBRETTO-001 study
FDA also approved the Oncomine Dx Target Test as a companion diagnostic for selpercatinib
Limitations of cfDNA for detection of FGFR2 fusions
Findings from an individual patient data based matched comparison of efficacy and safety between two commercial CAR T cell products
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
